{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:26:10Z","timestamp":1786998370326,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ymthe.2024.09.024","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:50:46Z","timestamp":1726595446000},"page":"3847-3864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations"],"prefix":"10.1016","volume":"32","author":[{"given":"John K.","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Loperfido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Baricordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"DeAndrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Treleaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Plasschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia N.","family":"Barese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yildirim","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Barbarossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenath","family":"Unnisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Kutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaroopa","family":"Guda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Oborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Maiwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Biasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek P.","family":"van Til","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.09.024_bib1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.09.024_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020302","article-title":"Gene Therapy Developments for Pompe Disease","volume":"10","author":"Unnisa","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2024.09.024_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm.2019.04.49","article-title":"An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond","volume":"7","author":"Korlimarla","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.21037\/atm.2019.05.56","article-title":"Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy","volume":"7","author":"Byrne","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jimd.12027","article-title":"The effectiveness of enzyme replacement therapy for juvenile-onset Pompe disease: A systematic review","volume":"42","author":"Joanne","year":"2019","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2024.09.024_bib6","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease: A 5-year prospective study","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2024.09.024_bib7","first-page":"733","article-title":"Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis","volume":"269","author":"Sarah","year":"2022","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jgm.1305","article-title":"Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease","volume":"11","author":"Douillard-Guilloux","year":"2009","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.omtm.2020.04.023","article-title":"Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease","volume":"17","author":"Stok","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2022.04.016","article-title":"Lentiviral gene therapy prevents anti-human acid alpha-glucosidase antibody formation in murine Pompe disease","volume":"25","author":"Liang","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtm.2016.12.010","article-title":"Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction","volume":"4","author":"Han","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1074\/jbc.M112.438663","article-title":"Glycosylation-independent lysosomal targeting of acid alpha-glucosidase enhances muscle glycogen clearance in pompe mice","volume":"288","author":"Maga","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.09.024_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.omtm.2022.09.010","article-title":"IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy","volume":"27","author":"Liang","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.omtm.2022.10.017","article-title":"Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease","volume":"27","author":"Dogan","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.09.024_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608653","article-title":"Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease","volume":"11","author":"Blanco","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib17","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1182\/blood-2009-11-252874","article-title":"Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype","volume":"115","author":"van Til","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.024_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.omtm.2016.11.002","article-title":"INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes","volume":"4","author":"Sherman","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12859-023-05390-1","article-title":"IS-Seq: a bioinformatics pipeline for integration sites analysis with comprehensive abundance quantification methods","volume":"24","author":"Yan","year":"2023","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.09.024_bib20","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","article-title":"Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection","volume":"117","author":"Biffi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.024_bib21","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1007\/s12035-017-0763-4","article-title":"A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.09.024_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","article-title":"Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression\u00a0meta-analysis","volume":"3","author":"Holtman","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2024.09.024_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-01099-x","article-title":"Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease","volume":"9","author":"Sobue","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2024.09.024_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/alz.12389","article-title":"Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease","volume":"18","author":"Boche","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ymthe.2024.09.024_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","article-title":"A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment","volume":"22","author":"Van Hove","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2024.09.024_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6375","article-title":"Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid alpha-glucosidase","volume":"9","author":"Puzzo","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/hum.2018.016","article-title":"Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease","volume":"30","author":"Keeler","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.024_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.21037\/atm.2019.04.67","article-title":"Progress and challenges of gene therapy for Pompe disease","volume":"7","author":"Ronzitti","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1152\/jn.00190.2021","article-title":"Case Studies in Neuroscience: Neuropathology and diaphragm dysfunction in ventilatory failure from late-onset Pompe disease","volume":"126","author":"Fuller","year":"2021","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/hmg\/ddu476","article-title":"Peripheral nerve and neuromuscular junction pathology in Pompe disease","volume":"24","author":"Falk","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.09.024_bib32","first-page":"55","article-title":"Rapidly Progressive White Matter Involvement in Early Childhood: The Expanding Phenotype of Infantile Onset Pompe?","volume":"39","author":"Broomfield","year":"2018","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymthe.2024.09.024_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-018-0771-0","article-title":"Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy","volume":"13","author":"Parini","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2024.09.024_bib34","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.21037\/jtd-cus-2020-007","article-title":"Respiratory failure and sleep-disordered breathing in late-onset Pompe disease: a narrative review","volume":"12","author":"Shah","year":"2020","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.ymthe.2024.09.024_bib35","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.09.024_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.resp.2016.02.007","article-title":"Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-\/-)) mice","volume":"227","author":"Turner","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.omtm.2018.11.002","article-title":"AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice","volume":"12","author":"Colella","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103052","article-title":"Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects","volume":"61","author":"Colella","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.09.024_bib39","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.ymthe.2022.05.022","article-title":"High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing","volume":"30","author":"Plasschaert","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.09.024_bib40","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.omtm.2020.07.001","article-title":"Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe Disease","volume":"18","author":"Piras","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib41","series-title":"Doctoral Thesis. A Step Forward: Lentiviral Gene Therapy as a Cure for Pompe Disease. Department of Hematology and Clinical Genetics, Erasmus University Medical Center","first-page":"161","author":"Liang","year":"2017"},{"key":"10.1016\/j.ymthe.2024.09.024_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101149","article-title":"Tagged IDS causes efficient and engraftment-independent prevention of brain pathology during lentiviral gene therapy for Mucopolysaccharidosis type II","volume":"31","author":"Catalano","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib43","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708730","article-title":"Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms","volume":"10","author":"Gleitz","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.09.024_bib45","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.omtm.2023.01.003","article-title":"Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease","volume":"28","author":"Saleh","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib47","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1089\/hum.2017.183","article-title":"Integration Site Analysis in Gene Therapy Patients: Expectations and Reality","volume":"28","author":"Biasco","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.024_bib48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood-2004-01-0282","article-title":"Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization","volume":"105","author":"Roeder","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.024_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12859-023-05269-1","article-title":"A mixed-effects stochastic model reveals clonal dominance in gene therapy safety studies","volume":"24","author":"Del Core","year":"2023","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2024.09.024_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.omtm.2017.10.002","article-title":"Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy","volume":"8","author":"Biasco","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib51","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood.2020010260","article-title":"Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency","volume":"138","author":"Reinhardt","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.024_bib52","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-12-756734","article-title":"Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients","volume":"129","author":"Cooper","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.09.024_bib53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s40291-021-00555-1","article-title":"Elivaldogene Autotemcel: First Approval","volume":"25","author":"Keam","year":"2021","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ymthe.2024.09.024_bib54","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.09.024_bib55","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41467-023-37262-w","article-title":"Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy","volume":"14","author":"Lauer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.09.024_bib56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjh.18179","article-title":"Haematopoietic stem cell gene therapy in inborn errors of metabolism","volume":"198","author":"Chiesa","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib57","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41587-022-01402-2","article-title":"Bluebird's CALD gene therapy poised for approval","volume":"40","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.omtm.2022.11.009","article-title":"Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing","volume":"28","author":"Cornetta","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.09.024_bib59","first-page":"102","article-title":"Using IVIM\/SAGA as screening tools during lentiviral vector lead selection for detection of clinically translatable insertional transformational risk","volume":"138","author":"Pfeifer","year":"2023","journal-title":"Worldsymposium. Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2024.09.024_bib60","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.09.024_bib61","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.4049\/jimmunol.1001888","article-title":"Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and alpha4beta7 integrin expression by NK cells","volume":"185","author":"Bouchentouf","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.09.024_bib62","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cyto.2011.09.023","article-title":"Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction","volume":"56","author":"Bouchentouf","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.ymthe.2024.09.024_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in\u00a0situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.ymthe.2024.09.024_bib64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jmoldx.2012.10.003","article-title":"Automated quantitative RNA in\u00a0situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinoma","volume":"15","author":"Wang","year":"2013","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.ymthe.2024.09.024_bib65","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/hum.2019.344","article-title":"Multiple Genes Surrounding Bcl-x(L), a Common Retroviral Insertion Site, Can Influence Hematopoiesis Individually or in Concert","volume":"32","author":"Ha","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.09.024_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.omtm.2016.11.003","article-title":"INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions","volume":"4","author":"Berry","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:29:21Z","timestamp":1783020561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624006063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1525001624006063"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.024","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.03.565442","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}